Armistice Capital’s Sanofi SNY Stock Holding History

Armistice Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.5M	Sell	300,000 -376,000	-56%	-$17.5M	0.26%	71
2025 Q4	$32.8M	Buy	676,000 +64,000	+10%	+$3.17M	0.39%	45
2025 Q3	$28.9M	Buy	+612,000	New	+$29.5M	0.43%	36
2025 Q2	–	Sell	-524,000	Closed	-$29.1M	–	263
2025 Q1	$29.1M	Sell	524,000 -724,000	-58%	-$39.2M	0.44%	45
2024 Q4	$60.2M	Buy	1,248,000 +668,000	+115%	+$34M	0.82%	25
2024 Q3	$33.4M	Sell	580,000 -920,000	-61%	-$49.7M	0.53%	35
2024 Q2	$72.8M	Buy	1,500,000 +202,000	+16%	+$9.74M	0.92%	12
2024 Q1	$63.1M	Buy	1,298,000 +262,000	+25%	+$12.8M	0.84%	12
2023 Q4	$51.5M	Buy	+1,036,000	New	+$50.7M	0.7%	27
2016 Q3	–	Sell	-138,000	Closed	-$5.78M	–	53
2016 Q2	$5.78M	Buy	+138,000	New	+$5.66M	2.2%	18

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital's SNY Position: Q1 2026 in Review

Armistice Capital reduced its Sanofi (SNY) stake by 56% in Q1 2026, selling an estimated $17.5M and leaving 300,000 shares worth $14.5M. The position accounts for 0.26% of the portfolio, ranked #71.

Armistice Capital first reported a position in SNY in Q2 2016 and has held it in 10 quarters since. The position peaked at $72.8M in Q2 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Armistice Capital held 300,000 shares of Sanofi worth $14.5M as of Q1 2026.
Armistice Capital sold 376,000 Sanofi shares in Q1 2026, an estimated $17.5M.
Sanofi made up 0.26% of Armistice Capital's portfolio in Q1 2026, its #71 holding.
Armistice Capital first reported a position in Sanofi in Q2 2016 and has held it in 10 quarters since.
Armistice Capital's Sanofi position peaked at $72.8M in Q2 2024.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.